Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5387-5393
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5387
Table 1 Results of laboratory tests performed at our hospital

Index
Result
Reference range
Blood countWhite blood cell count (109/L)7.233.6-9.7
Hemoglobin (g/L)120110-146
Platelet count (109/L)379100-450
Urinary chemistryUrinary protein (g/24 h)2.510-0.15
Urinary protein4+Negative
Urinary red blood cell count (cells/HP)4+0-3
Urinary leukocyte count (cells/HP)4+0-5
Pathological castsPositiveNegative
Serum chemistryAlbumin (g/L)2035-50
Total cholesterol (mmol/L)6.29< 5.18
Triglyceride (mmol/L)1.38< 1.7
Blood urea nitrogen (mmol/L)4.763.2-7.1
Serum creatinine (μmol/L)3517.3-54.6
ImmunologyImmunoglobulin G (g/L)2.215.29-21.9
Immunoglobulin A (g/L)0.390.41-3.95
Immunoglobulin M (g/L)0.960.48-2.26
Immunoglobulin E (g/L)17.2< 90
Complement C3 (g/L)0.980.7-2.06
Complement C4 (g/L)0.180.11-0.61
Complement C1q (mg/dL)23.915.7-23.7
Table 2 Results of urinalysis during follow-up
Time of follow-up (d)
Urinary proteinuria
Urinary RBC count (cells/μL)
Urinary WBC count (cells/μL)
Urinary pathologic casts (cells/μL)
04+10669814
162+28090
603+325340
773+168991.94.81
1183+1286140
130Negative5330
144Negative59100
Table 3 Differences between idiopathic membranous nephropathy and minimal change disease in children


IMN
MCD
General featuresSexMaleMale
AgeAdolescencePreschool age
Clinical manifestationsNephrotic syndromeCommonCommon
LeukocyturiaSomeRare
HematuriaSomeRare
HypertensionSomeRare
Renal failureSomeRare
Laboratory testsAnti-PLA2R, antibodyElevatedNormal
Anti-THSD7A, antibodyElevatedNormal
Treatment strategyPrednisoneMostly resistanceMostly sensitive
ImmunosuppressantTacrolimus, cyclophosphamide, mycophenolate mofetilRare
Biological agentRituximabRare